Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Immediate breast reconstruction with anatomical implants following mastectomy: The radiation perspective

Journal Article · · Medical Dosimetry
 [1];  [1];  [2];  [3]
  1. Radiation Oncology Unit, Chaim Sheba Medical Center, Ramat Gan (Israel)
  2. Statistical Laboratory, School of Mathematics, Tel Aviv University, Tel Aviv (Israel)
  3. Department of Surgery, Assuta and Herzliya Medical Centers, Ramat Gan (Israel)
Immediate implant-based breast reconstruction followed by postmastectomy radiation therapy (PMRT) is controversial because of the risk of compromised treatment plans and concerns regarding cosmetic outcomes. We evaluated the effects of immediate direct-to-implant breast reconstruction with anatomical implants on the quality of PMRT delivered by 3-dimensional conformal radiotherapy (3D-CRT). In this retrospective, single-institution study, patients who had undergone reconstruction with direct anatomic implant, performed by a single surgeon, received 3D-CRT between 2008 and 2013. For each patient, 2 plans (including or excluding internal mammary nodes [IMN]) were created and calculated. The primary end point was the dose distribution among reconstructed breasts, heart, lungs, and IMNs, and between right and left breasts. Of 29 consecutive patients, 11 received right-sided and 18 received left-sided PMRT to a total dose of 50 Gy. For plans excluding IMN coverage, mean D{sub mean} for right and left reconstructed breasts was 49.09 Gy (98.2% of the prescribed dose) and 48.51 Gy (97.0%), respectively. For plans including IMNs, mean D{sub mean} was 49.15 Gy (98.3%) for right and 48.46 Gy (96.9%) for left reconstructed breasts; the mean IMN D{sub mean} was 47.27 Gy (right) and 47.89 Gy (left). Heart D{sub mean} was below 1.56 Gy for all plans. Mean total lung volume receiving a dose of ≥ 20 Gy was 13.80% to 19.47%. PMRT can be delivered effectively and safely by 3D-CRT after direct-to-implant breast reconstruction with anatomical implants, even if patients require IMN treatment.
OSTI ID:
22577875
Journal Information:
Medical Dosimetry, Journal Name: Medical Dosimetry Journal Issue: 2 Vol. 41; ISSN 0958-3947
Country of Publication:
United States
Language:
English

Similar Records

Quantifying dose to the reconstructed breast: Can we adequately treat?
Journal Article · Mon Apr 01 00:00:00 EDT 2013 · Medical Dosimetry · OSTI ID:22262791

Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy
Journal Article · Tue Apr 01 00:00:00 EDT 2014 · Medical Dosimetry · OSTI ID:22267962

Quantifying the Impact of Immediate Reconstruction in Postmastectomy Radiation: A Large, Dose-Volume Histogram-Based Analysis
Journal Article · Mon Oct 01 00:00:00 EDT 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:22149500